These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24140401)

  • 21. Emerging drugs of abuse.
    Nelson ME; Bryant SM; Aks SE
    Emerg Med Clin North Am; 2014 Feb; 32(1):1-28. PubMed ID: 24275167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015.
    Law R; Schier J; Martin C; Chang A; Wolkin A;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):618-9. PubMed ID: 26068566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of psychostimulants in a sexual context: Analysis of cases reported to the French network of Addictovigilance Centers].
    Batisse A; Peyrière H; Eiden C; Courné MA; Djezzar S;
    Therapie; 2016 Oct; 71(5):447-455. PubMed ID: 27203172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
    Wood DM; Sedefov R; Cunningham A; Dargan PI
    Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New synthetic drugs in addictovigilance.
    Chavant F; Boucher A; Le Boisselier R; Deheul S; Debruyne D
    Therapie; 2015; 70(2):167-89. PubMed ID: 25858573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
    Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
    Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bath salts and other emerging toxins.
    Thornton MD; Baum CR
    Pediatr Emerg Care; 2014 Jan; 30(1):47-52; quiz 53-5. PubMed ID: 24378862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of new psychoactive substances: A retrospective study in hair.
    Rust KY; Baumgartner MR; Dally AM; Kraemer T
    Drug Test Anal; 2012 Jun; 4(6):402-8. PubMed ID: 22522922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating the 'bath salt' panic: the rarity of synthetic cathinone use among students in the United States.
    Stogner JM; Miller BL
    Drug Alcohol Rev; 2013 Sep; 32(5):545-9. PubMed ID: 23718639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kratom exposures reported to Texas poison centers.
    Forrester MB
    J Addict Dis; 2013; 32(4):396-400. PubMed ID: 24325774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations.
    Soussan C; Kjellgren A
    Int J Drug Policy; 2016 Jun; 32():77-84. PubMed ID: 27184218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harms associated with psychoactive substances: findings of the UK National Drug Survey.
    Morgan CJ; Muetzelfeldt L; Muetzelfeldt M; Nutt DJ; Curran HV
    J Psychopharmacol; 2010 Feb; 24(2):147-53. PubMed ID: 19939875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic cannabinoid and cathinone use among US soldiers.
    Berry-Cabán CS; Kleinschmidt PE; Rao DS; Jenkins J
    US Army Med Dep J; 2012; ():19-24. PubMed ID: 23007932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adolescent synthetic cannabinoid exposures reported to Texas poison centers.
    Forrester MB
    Pediatr Emerg Care; 2012 Oct; 28(10):985-9. PubMed ID: 23023462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicology and management of novel psychoactive drugs.
    Kersten BP; McLaughlin ME
    J Pharm Pract; 2015 Feb; 28(1):50-65. PubMed ID: 25261428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhalant abuse: monitoring trends by using poison control data, 1993-2008.
    Marsolek MR; White NC; Litovitz TL
    Pediatrics; 2010 May; 125(5):906-13. PubMed ID: 20403928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities.
    Elliott L; Haddock CK; Campos S; Benoit E
    PLoS One; 2019; 14(12):e0225273. PubMed ID: 31794586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
    Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010.
    Hoyte CO; Jacob J; Monte AA; Al-Jumaan M; Bronstein AC; Heard KJ
    Ann Emerg Med; 2012 Oct; 60(4):435-8. PubMed ID: 22575211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.